Bibliografía
1. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem J. 1984; 220;597-600.
2. Fraser JR, Laurent TC and Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997; 242;27-33.
3. Arai H, Kang KY, Sato H, et al. Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Respir Dis. 1979; 120;529-532.
4. Hopwood JJ and Dorfman A. Glycosaminoglycan synthesis by Wilms' tumor. Pediatr Res. 1978; 12;52-56.
5. Wang C, Tammi M, Guo H and Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol. 1996; 148;1861-1869.
6. Sowa M, Kato Y, Nishimura M, Yoshino H, Kubo T and Umeyama K. Clinico-histochemical studies on type 4 carcinoma of the stomach--with special reference to mucopolysaccharides and sialic acid in tumor tissue. Jpn J Surg. 1989; 19;153-162.
7. Setala LP, Tammi MI, Tammi RH, et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer. 1999; 79;1133-1138.
8. Llaneza A, Vizoso F, Rodriguez JC, et al. Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br J Surg. 2000; 87;1690-1696.
9. Vizoso FJ, del Casar JM, Corte MD, et al. Significance of cytosolic hyaluronan levels in gastric cancer. Eur J Surg Oncol. 2004; 30;318-324.
10. Takeuchi J, Sobue M, Sato E, Shamoto M and Miura K. Variation in glycosaminoglycan components of breast tumors. Cancer Res. 1976; 36;2133-2139.
11. Bertrand P, Girard N, Delpech B, Duval C, d'Anjou J and Dauce JP. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int J Cancer. 1992; 52;1-6.
12. Ponting J, Howell A, Pye D and Kumar S. Prognostic relevance of serum hyaluronan levels in patients with breast cancer. Int J Cancer. 1992; 52;873-876.
13. Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol. 2000; 156;529-536.
14. de la Torre M, Wells AF, Bergh J and Lindgren A. Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol. 1993; 24;1294-1297.
15. Goebeler M, Kaufmann D, Brocker EB and Klein CE. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci. 1996; 109 ( Pt 7);1957-1964.
16. Catterall JB, Jones LM and Turner GA. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metastasis. 1999; 17;583-591.
17. Rooney P, Kumar S, Ponting J and Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer. 1995; 60;632-636.
18. Zhang L, Underhill CB and Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995; 55;428-433.
19. Rudzki Z and Jothy S. CD44 and the adhesion of neoplastic cells. Mol Pathol. 1997; 50;57-71.
20. Auvinen PK, Parkkinen JJ, Johansson RT, et al. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer. 1997; 74;477-481.
21. Wernicke M, Pineiro LC, Caramutti D, et al. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol. 2003; 16;99-107.
22. Corte MD, Gonzalez LO, Lamelas ML, et al. Expression and Clinical Signification of Cytosolic Hyaluronan Levels in Invasive Breast Cancer. Breast Cancer Res Treat. 2006;
23. Consensus conference on the classification of ductal carcinoma in situ. Hum Pathol. 1997; 28;1221-1225.
24. Bloom HJ and Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957; 11;359-377.
25. Knudson W, Biswas C and Toole BP. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci U S A. 1984; 81;6767-6771.
26. Brown CT, Applebaum E, Banwatt R and Trinkaus-Randall V. Synthesis of stromal glycosaminoglycans in response to injury. J Cell Biochem. 1995; 59;57-68.
27. Udabage L, Brownlee GR, Waltham M, et al. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res. 2005; 65;6139-6150.
28. Udabage L, Brownlee GR, Nilsson SK and Brown TJ. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res. 2005; 310;205-217.
29. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995; 345;1154-1157.
30. Kosunen A, Ropponen K, Kellokoski J, et al. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol. 2004; 40;257-263.
|